Pappa T, Ahmadi S, Marqusee E, Johnson HL, et al. Oncogenic mutations in PI3K/AKT/mTOR pathway effectors associate with worse prognosis in BRAF(V600E)-driven papillary thyroid cancer patients. Clin Cancer Res 2021 Jun 4. pii: 1078-0432.CCR-21-0874.
PMID: 34088725